Dornier MedTech, known as a pioneer and market leader in the urology market, continues to provide innovative therapeutic, diagnostic and service solutions worldwide for numerous healthcare fields. Working closely with other leading medical organizations, Dornier develops, manufactures, markets and services lithotripters, orthopedic shock wave devices, urology surgical tables, surgical lasers - and more. Dornier MedTech is headquartered in Munich, Germany, and its principal shareholders are Accuron Technologies Limited and EADS. As the inventor of the first lithotripter and extracorporeal shockwave lithotripsy (ESWL), Dornier continues to revolutionize the urology market with distinctive lithotripters and urology imaging tables and has the largest installed base of over 1,500 lithotripters worldwide. Using this innovative technology, Dornier further developed extracorporeal shockwave therapy (ESWT), the treatment principle for its orthopaedic shockwave device. Dornier has been consistently acknowledged as the top after-sales service provider in the field, with satisfied customers praising Dornier's efficiency and technical expertise.
In the area of medical lasers, Dornier also sets new standards with the continued development of quality lasers and cost-effective application solutions. With several thousand installations of Dornier Medilas lasers worldwide, Dornier is well positioned to develop new laser therapies to improve treatment outcomes and quality of life of individuals around the world.